Drs. Bauman and Ward are recognized for collaborating with Lawson Imaging scientists to improve the diagnosis and treatment of prostate cancer. The team is the first in Canada to capture highly specific prostate cancer images using a new molecule known as a prostate-specific membrane antigen (PSMA) probe.
Over the past 50 years, Dr. Peeyush Lala has led a career dedicated to the fields of placental biology and cancer biology. He has built a unique bridge between the two disciplines by progressing understanding of the mechanisms that control cell migration and tissue invasion. Recognizing his many accomplishments and accolades, Dr. Lala was presented with the 2017 Lawson Career Scientist Award at the 2017 Lawson Impact Awards this past spring.
Left to right: John Patrick, TELUS Ride for Dad London; Steve Dunley, TELUS Ride for Dad Grey Bruce; Elaine Hammell-Stevenson, TELUS Ride for Dad Grey Bruce; Bryce Stevenson, TELUS Ride for Dad Grey Bruce; and Dr. Alison Allan, Lawson scientist.
Circulating tumour cells (CTCs) are cancer cells that leave a tumour, enter the blood stream and invade other parts of the body. In a new study funded by the TELUS Ride for Dad London and Grey Bruce, Lawson Health Research Institute’s Dr. Alison Allan will test whether the analysis of CTCs can predict which prostate cancer treatments will be most effective for individual patients.